Table 1.

Effect of chromanol 293B on motility parameters during human sperm capacitation. Values represent the means ± SEM of 5 experiments.

	DMSO	100μM Chromanol 293B	200μM Chromanol 293B
Motility (%)	67.06 ± 1.33	63.26 ± 0.80*	34.30 ± 1.24*
Progressive motility (%)	46.76 ± 1.13	42.89 ± 0.89*	21.90 ± 0.66*
VAP (μm/s)	81.81 ± 1.64	78.52 ± 1.40	70.17 ± 1.07*
VSL (μm/s)	72.25 ± 1.62	69.01 ± 1.33	59.46 ± 0.95*
VCL (μm/s)	130.33 ± 2.66	126.99 ± 2.78	118.95 ± 1.91*
ALH (μm)	5.65 ± 0.14	5.52 ± 0.14	5.91 ± 0.07
BCF (Hz)	31.48 ± 0.29	32.01 ± 0.31	25.67 ± 0.29*
STR (%)	85.12 ± 0.42	84.50 ± 0.38	81.90 ± 0.31*
LIN (%)	54.06 ± 0.44	53.10 ± 0.38	49.30 ± 0.45*
Hyperactivation(%)	7.00 ± 0.54	7.01 ± 0.82	7.70 ± 0.68

^*p<0.05.

VAP, average path velocity; VSL, straight line velocity; VCL, curvilinear velocity; ALH, amplitude of lateral head displacement; BCF, beat-cross frequency; STR, straightness (VSL/VAP multiplied by 100); LIN, linearity (VSL/VCL multiplied by 100); Hyperactivation, VCL≥150μm/s, ALH≥7.0μm, and LIN≤50%.